By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Mira Dx today announced it is licensing technology from Yale University for the identification of patients at risk for triple negative breast cancer.
Financial and other terms of the deal were not disclosed.
...and receive Daily News bulletins.
Already have an account?Login Now.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.
In Science this week: genetic overlap among many psychiatric disorders, and more.
The Economist writes that an increasing number of scientific journals don't do peer review.
This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research.